Lungs

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows…

Pneumonia is a disease that burdens the healthcare system with more that 1.2 million emergency room visits each…

A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same…

Recovery from deadly influenza infection may hinge on helping the lungs heal in addition to stopping the virus,…

When doctors detect elevated levels of SerpinB3 in a blood test, it can signal that something is seriously…

Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people…

The bacterium known as Pseudomonas aeruginosa is an unwelcome visitor in the human body. Serious infections can result…

New findings from Ontario’s largest birth cohort reveal that sulfate and ammonium particles in fine air pollution may…

More than half of all premature babies born before the 28th week of pregnancy develop respiratory distress syndrome…

For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group,…

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease…

Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic Fibrosis